Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.

<h4>Objectives</h4>Transfusion of allogeneic blood is still common in orthopedic surgery. This analysis evaluates from the perspective of a German hospital the potential cost savings of Epoetin alfa (EPO) compared to predonated autologous blood transfusions or to a nobloodconservationstr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jörg Tomeczkowski, Sean Stern, Alfred Müller, Christian von Heymann
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2013
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/0259d8605b9745049da6bee89c31c46c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0259d8605b9745049da6bee89c31c46c
record_format	dspace
spelling	oai:doaj.org-article:0259d8605b9745049da6bee89c31c46c2021-11-18T08:56:22ZPotential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.1932-620310.1371/journal.pone.0072949https://doaj.org/article/0259d8605b9745049da6bee89c31c46c2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24039829/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>Transfusion of allogeneic blood is still common in orthopedic surgery. This analysis evaluates from the perspective of a German hospital the potential cost savings of Epoetin alfa (EPO) compared to predonated autologous blood transfusions or to a nobloodconservationstrategy (allogeneic blood transfusion strategy)during elective hip and knee replacement surgery.<h4>Methods</h4>Individual patients (N = 50,000) were simulated based on data from controlled trials, the German DRG institute (InEK) and various publications and entered into a stochastic model (Monte-Carlo) of three treatment arms: EPO, preoperative autologous donation and nobloodconservationstrategy. All three strategies lead to a different risk for an allogeneic blood transfusion. The model focused on the costs and events of the three different procedures. The costs were obtained from clinical trial databases, the German DRG system, patient records and medical publications: transfusion (allogeneic red blood cells: €320/unit and autologous red blood cells: €250/unit), pneumonia treatment (€5,000), and length of stay (€300/day). Probabilistic sensitivity analyses were performed to determine which factors had an influence on the model's clinical and cost outcomes.<h4>Results</h4>At acquisition costs of €200/40,000 IU EPO is cost saving compared to autologous blood donation, and cost-effective compared to a nobloodconservationstrategy. The results were most sensitive to the cost of EPO, blood units and hospital days.<h4>Conclusions</h4>EPO might become an attractive blood conservation strategy for anemic patients at reasonable costs due to the reduction in allogeneic blood transfusions, in the modeled incidence of transfusion-associated pneumonia andthe prolongedlength of stay.Jörg TomeczkowskiSean SternAlfred MüllerChristian von HeymannPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e72949 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Jörg Tomeczkowski Sean Stern Alfred Müller Christian von Heymann Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
description	<h4>Objectives</h4>Transfusion of allogeneic blood is still common in orthopedic surgery. This analysis evaluates from the perspective of a German hospital the potential cost savings of Epoetin alfa (EPO) compared to predonated autologous blood transfusions or to a nobloodconservationstrategy (allogeneic blood transfusion strategy)during elective hip and knee replacement surgery.<h4>Methods</h4>Individual patients (N = 50,000) were simulated based on data from controlled trials, the German DRG institute (InEK) and various publications and entered into a stochastic model (Monte-Carlo) of three treatment arms: EPO, preoperative autologous donation and nobloodconservationstrategy. All three strategies lead to a different risk for an allogeneic blood transfusion. The model focused on the costs and events of the three different procedures. The costs were obtained from clinical trial databases, the German DRG system, patient records and medical publications: transfusion (allogeneic red blood cells: €320/unit and autologous red blood cells: €250/unit), pneumonia treatment (€5,000), and length of stay (€300/day). Probabilistic sensitivity analyses were performed to determine which factors had an influence on the model's clinical and cost outcomes.<h4>Results</h4>At acquisition costs of €200/40,000 IU EPO is cost saving compared to autologous blood donation, and cost-effective compared to a nobloodconservationstrategy. The results were most sensitive to the cost of EPO, blood units and hospital days.<h4>Conclusions</h4>EPO might become an attractive blood conservation strategy for anemic patients at reasonable costs due to the reduction in allogeneic blood transfusions, in the modeled incidence of transfusion-associated pneumonia andthe prolongedlength of stay.
format	article
author	Jörg Tomeczkowski Sean Stern Alfred Müller Christian von Heymann
author_facet	Jörg Tomeczkowski Sean Stern Alfred Müller Christian von Heymann
author_sort	Jörg Tomeczkowski
title	Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
title_short	Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
title_full	Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
title_fullStr	Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
title_full_unstemmed	Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
title_sort	potential cost saving of epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
publisher	Public Library of Science (PLoS)
publishDate	2013
url	https://doaj.org/article/0259d8605b9745049da6bee89c31c46c
work_keys_str_mv	AT jorgtomeczkowski potentialcostsavingofepoetinalfainelectivehiporkneesurgeryduetoreductioninbloodtransfusionsandtheirsideeffectsadiscreteeventsimulationmodel AT seanstern potentialcostsavingofepoetinalfainelectivehiporkneesurgeryduetoreductioninbloodtransfusionsandtheirsideeffectsadiscreteeventsimulationmodel AT alfredmuller potentialcostsavingofepoetinalfainelectivehiporkneesurgeryduetoreductioninbloodtransfusionsandtheirsideeffectsadiscreteeventsimulationmodel AT christianvonheymann potentialcostsavingofepoetinalfainelectivehiporkneesurgeryduetoreductioninbloodtransfusionsandtheirsideeffectsadiscreteeventsimulationmodel
_version_	1718421121930362880

Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.

Ejemplares similares